The second part of this three-part series on executing an effective remediation program starts by looking at primary versus secondary root causes. A robust quality system provides an assurance of high-quality production efforts and products. NSF recommends that a systems-based approach to remediation and corrective action is the most successful approach. Also, a system- based approach is recognised globally with, regulators such as the MHRA and FDA.
Executing a successful remediation program: part 2 of 3
Learn how NSF's Pharma Biotech experts help clients with remediation strategy, including FDA Warning Letters.
You may also like
Regulatory
![NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development]()
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development
Read moreThe discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges around regulatory benchmarking and operational consistency
Trending Articles
You may also like
Regulatory
![NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development]()
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development
The discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges around regulatory benchmarking and operational consistency
